Emcure Pharmaceuticals IPO to Open on July 03, 2024

 

Mumbai: “Emcure Pharmaceuticals Limited”, a research-led global pharmaceutical company, is set to launch its initial public offering (IPO) of equity shares on Wednesday, July 03, 2024. The IPO's Anchor Investor Bid/Offer Period is scheduled for Tuesday, July 02, 2024, one day prior to the official opening. The Bid/Offer will close on Friday, July 05, 2024.

The price band for the offer has been fixed from ₹960 to ₹1008 per equity share, each with a face value of ₹10. Bids can be placed for a minimum of 14 equity shares and multiples of 14 thereafter.

The IPO comprises a fresh issue of equity shares aggregating up to ₹8,000 million by the company and an offer for sale of up to 11,428,839 equity shares by various selling shareholders, including promoter and promoter group selling shareholders, an investor selling shareholder, and other individual selling shareholders. The offer also includes a reservation for eligible employees, who will receive a discount of up to ₹90 per equity share.

The equity shares will be listed on both BSE Limited (BSE) and the National Stock Exchange of India Limited (NSE). Kotak Mahindra Capital Company Limited, Axis Capital Limited, Jefferies India Private Limited, and J.P. Morgan India Private Limited are the Book Running Lead Managers for the IPO.